Using binaural sound to enhance anesthesia induction with remimazolam
The Effect of Preoperative Binaural Sound on Remimazolam Dose Required for Induction of General Anesthesia: a Randomized, Placebo-controlled Trial
NA · Gangnam Severance Hospital · NCT06099977
This study tests if listening to binaural sound can help patients fall asleep faster when getting anesthesia with remimazolam.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 72 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Gangnam Severance Hospital (other) |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06099977 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of binaural sound in reducing the time it takes for patients to lose consciousness during general anesthesia induction with remimazolam. The study involves administering binaural sound alongside a remimazolam infusion to assess its impact on anesthesia induction times. Participants will be monitored for their response to the sound and medication combination. The goal is to determine if this approach can improve the efficiency of anesthesia induction.
Who should consider this trial
Good fit: Ideal candidates are patients aged 20-60 scheduled for general anesthesia with a physical status classification of 1-2 and an ideal body weight of 50-80 kg.
Not a fit: Patients with hearing disabilities, recent opioid or sedative use, or certain medical conditions such as cardiovascular disease or liver failure may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to faster and more efficient anesthesia induction for patients undergoing surgery.
How similar studies have performed: While the use of binaural sound in anesthesia is a novel approach, similar studies exploring sound therapy in medical settings have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients scheduled for generla anesthesia 2. Patients aged 20-60 3. Patients with American Society of Anesthesiologist physical status classification 1-2 4. Patients with ideal body weight 50-80 kg Exclusion Criteria: 1. Patients with hearing disability 2. Patients using opioids or sedatives in 1 week 3. Patients who are dependent for alcoholics or drugs 4. Patients with hypersensitivities to remimazolam 5. Patients with arrhythmia, cardiovascular disease, heart failure, or hypovolemia 6. Patients with liver failure
Where this trial is running
Seoul
- GangnamSeveranceHospital — Seoul, Korea, Republic of (RECRUITING)
Study contacts
- Study coordinator: Hyun-Chang Kim
- Email: onidori@yuhs.ac
- Phone: 82-2-2224-3919
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: General Anesthesia, Prostate Cancer, Uterine Myoma